Adams Clinical Harlem — New York, New York

Adams Clinical Harlem is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Adams Clinical Harlem has participated in 8 clinical trials with 8 currently active.

Therapeutic areas: Generalized Anxiety Disorder, Major Depressive Disorder, Opioid Use Disorder.

Sponsors: Definium Therapeutics US, Inc., Cybin IRL Limited, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Adams Clinical Harlem?

Adams Clinical Harlem has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Adams Clinical Harlem conducted?

Adams Clinical Harlem has 8 clinical trials on record, with 8 currently active. Their work covers Generalized Anxiety Disorder, Major Depressive Disorder, Opioid Use Disorder.

Is Adams Clinical Harlem accredited by Crixeo Health?

Yes — Adams Clinical Harlem holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Adams Clinical Harlem?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.